VentriPoint Diagnostics Ltd
TSXV:VPTView on OTCQB

  • LAST PRICE
    0.1350
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    0.1300/ 111
  • Ask / Lots
    0.1400/ 493
  • Open / Previous Close
    0.1350 / 0.1350
  • Day Range
    0.1350
    0.1450
  • 52 Week Range
    0.1150
    0.3600
  • Volume
    67,219

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

  • Nov 22, 2024

      Show headlines and story abstract

    • 4:26PM ET on Friday Nov 22, 2024 by Dow Jones
      Companies Mentioned: VPT

      November, 22, 2024 -- (Ventripoint Diagnostics Ltd.) -- (TheNewswire)

      Toronto, Ontario, November 22, 2024 -- TheNewswire - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Corporation", TSXV:VPT) is pleased to announce that it has closed the previously announced Shares for Debt Settlement transactions (see press release dated November 6, 2024) to settle an aggregate of $19,335 of debt owed to a former director and a holding company of the former director of the Corporation (the "Creditors") by issuing an aggregate of 128,900 common shares (the "Shares") of the Corporation at a deemed price of $0.15 per share. The Shares are subject to a hold period of four-month and one day. The Corporation determined to satisfy the indebtedness with Shares in order to preserve its cash for development of its business. Issuance of shares is subject to approval by the TSX Venture Exchange. The Shares are subject to a hold period of four months and one day.

  • Nov 19, 2024

  • Nov 14, 2024

  • Nov 6, 2024

      Show headlines and story abstract

    • 8:17AM ET on Wednesday Nov 06, 2024 by Dow Jones
      Companies Mentioned: VPT

      November, 06, 2024 -- (Ventripoint Diagnostics Ltd.) -- (TheNewswire)

      Toronto, Ontario -- TheNewswire - November 6, 2024 -- Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Corporation"), (TSXV:VPT) announces that it intends to complete, subject to TSXV Venture Exchange (the "Exchange") acceptance, an amended non-brokered private placement of up to CDN$1,000,000 (the "Offering") of unsecured convertible debentures ("Debentures"). Debentures issued pursuant to the Offering will be convertible at CDN$0.15 for the first year of the term, CDN$0.195 for the second year of the term and at CDN$0.25 thereafter. The Corporation had previously announced (see press releases dated October 15, 2024, September 20, 2024, and August 28, 2024) a non-brokered private placement of up to CDN$3,000,000 principal amount of unsecured convertible debentures, convertible at CDN$0.195 during the first year of the term and CDN$0.25 thereafter, the closing of the first tranche and subsequent extension of the previous offering. The previous offering has been terminated and replaced with the new Offering. Depending on market conditions, the Corporation may increase the size of the Offering, subject to approval of the Exchange.

Peers Headlines